Prior Stephen David (CIK 2042268) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-07). Recent activity: Sell ANTX (3,604 shares), Sell ANTX (2,858 shares), Sell ANTX (765 shares), Buy ANTX (28,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-07 | AN2 Therapeutics, Inc. (ANTX) | Chief Strategy Officer | Sell | 3,604 | $3,604 |
| 2026-01-07 | AN2 Therapeutics, Inc. (ANTX) | Chief Strategy Officer | Sell | 2,858 | $2,887 |
| 2025-11-06 | AN2 Therapeutics, Inc. (ANTX) | Chief Strategy Officer | Sell | 765 | $872 |
| 2025-02-28 | AN2 Therapeutics, Inc. (ANTX) | Chief Strategy Officer | Buy | 28,000 | $0 |
Source: SEC Form 4 filings · as of 2026-01-07